Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway

Author(s): Jiezhong Chen, Andrew Katsifis, Changhua Hu, Xu-Feng Huang

Journal Name: Current Drug Discovery Technologies

Volume 8 , Issue 2 , 2011

Become EABM
Become Reviewer


Obesity has been associated with both the carcinogenesis and poor prognosis of colon cancer, one of the leading causes of cancer-related death. Increased blood levels of insulin in obese subjects have been demonstrated to play a key role in carcinogenesis. It is also possible that insulin affects treatment efficacy, leading to poor prognosis. In this study, we demonstrated that insulin can increase HT29 colon cancer cell line resistance to cycloheximide and 5- fluorouracil induced cytotoxicity. This effect can be inhibited by the PI3K/Akt inhibitor Ly294002, indicating the important role of this pathway in the insulin-induced inefficacy of chemotherapy. The insulin-induced resistance to cycloheximide and 5-fluorouracil can be used in drug screening to overcome the inefficacy of chemotherapy in obesity-associated colon cancer.

Keywords: Insulin, PI3K/Akt pathway, cycloheximide, 5-fluorouracil, cytotoxicity, Ly294002, obesity, HT29 cells, colon cancer

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [119 - 125]
Pages: 7
DOI: 10.2174/157016311795563820
Price: $65

Article Metrics

PDF: 29